“We are excited to be working with Tom Strauss, who has a long and established track record of forward-looking, innovative leadership in the hospital industry.”
Washington, DC (PRWEB) January 07, 2016
NaviMed Capital, a leading healthcare focused private equity firm based in Washington, DC, today announced the expansion of its team with the addition of an experienced hospital executive as a Senior Advisor to the firm and the recent hiring of two investment Associates.
- Thomas Strauss – Senior Advisor
Mr. Strauss is the former President & CEO, of Summa Health System, a major Ohio-based healthcare system with $1.6 billion of revenue. During his 15-year tenure and under his leadership, Summa Health System generated a $2.9 billion economic impact. With approximately 10,000 employees, it is the largest employer in all five counties that it serves. In prior years, Mr. Strauss spent ten years at Meridia Cleveland Clinic in leadership roles where he established new ventures, turned around programs and services, and increased market share. In addition, he worked at Baxter Healthcare.
Mr. Strauss received his Doctor of Pharmacy and his Bachelor of Science both from Duquesne University in Pittsburgh. He was Board Chair at Greater Akron Chamber of Commerce, Board Member at Premier, Austen BioInnovation Institute, United Way of Summit County, Team.NEO, BioEnterprise, and Akron Tomorrow. He is the recipient of the Outstanding Fundraiser Award, Community Service Award, Northeast Ohio Business Hall of Fame and was named Non-Profit Executive of the Year, Pillar Award for Community Service.
- Cyrus Peyrovian – Associate
Prior to joining NaviMed Capital, Mr. Peyrovian was part of the Business Development team at Healthagen, a division of Aetna focused on providing a suite of payer-neutral population health management services and HIT solutions. Based out of New York, he supported Healthagen’s portfolio of businesses, including Accountable Care Solutions, Medicity, and Active Health, through partnership, investment, and acquisition activities.
Mr. Peyrovian started his career as an investment banking analyst at SunTrust Robinson Humphrey, focused on M&A advisory and capital raising transactions across a number of healthcare sectors.
Mr. Peyrovian holds a BS in Finance and Operations Management from the University of Maryland.
- Ryan Ross – Associate
Prior to joining NaviMed Capital, Mr. Ross was an Associate at Capitala Group, a provider of capital to lower and traditional middle-market companies through its family of funds. Based out of Charlotte, NC, he supported the origination and execution of over 15 investments, including control equity, minority equity, and subordinated in transactions such as leveraged buyouts, management buyouts, add-on acquisitions, and growth financings. Notable transactions include the acquisition of a hospice provider, the acquisition of medical device manufacturer, and the growth financing of bioscience company, along with multiple add-ons acquisitions.
Mr. Ross holds a BS in Finance from East Carolina University.
These three additions join a NaviMed senior investment team that has a track record of value creation spanning dozens of investments and more than $6.5 billion of enterprise value created with more than 50 years of combined healthcare investing and operating experience.
“As we pursue new growth investment opportunities, all of us at NaviMed are very excited to be expanding our team with such high quality and experienced individuals,” said Brian Canann, Managing Director of NaviMed Capital. “We are particularly excited to be working with Tom Strauss, who has a long and established track record of forward-looking, innovative leadership in the hospital industry.”
About NaviMed Capital
NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes substantial investments in fast growing lower middle-market healthcare businesses. The firm focus on healthcare services, healthcare IT, hospital products, and distribution businesses which are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which can benefit from its deep industry expertise, broad relationship network and combined 50+ year track record of success as healthcare investors and operators. NaviMed’s senior investment team has a track record of value creation spanning dozens of investments and more than $6.5 billion of enterprise value created.
For more information, please visit http://www.navimed.com